Yolanda Sanz talk about microbioma and regulatory challenges at the IMI Stakeholder Forum 2017

Dr. Yolanda Sanz, from the IATA's Microbial Ecology, Nutrition and Health Group, has participated as a speaker at the Microbiome Forum of the Innovative Medicines Initiative of the European Commission (IMI Stakeholder Forum 2017) that took place on October 19, 2017 in Brussels. The title of her talk was "Regulatory challenges in the drug-food continuum"

The microbiome has come under the spotlight in recent years for its potential to be a turning point in medical research. The challenges it entails, however, require breakthrough collaboration between a diverse range of leading health stakeholders, from both the private and public sectors.
This event brought together the pharmaceutical, food / feed and diagnostics industries for an open and dynamic discussion with medtechs, regulators, researchers and other players on the needs for and benefits of collaborative research in the microbiome field.

See Presentation